A direct comparison between the results of GK and fractionated radiotherapy is difficult to perform because patients selected to undergo GK may have more favorable characteristics, that is, smaller tumor size and lower GH levels, than those receiving fractionated radiotherapy. The gene discussed is GH1; the disease is neoplasm.